Live Attenuated Human Hookworm Vaccine Shows Promise
Researchers conducted a study to assess the effects of a novel, live attenuated human hookworm vaccine.
Vaccination
NASEM: Building Parents’ Confidence in COVID-19 Vaccines
Having the tough conversations. NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
FDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster Shots
Panel will consider whether third Moderna shot should contain half the original dose, best timing for second shot of single-dose J&J vaccine.
FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk
An expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.
World Health Organization Releases Updated Guidelines on Treatment Strategies for COVID-19
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
T-Cell and Humoral Response to SARS-CoV-2 Vaccine in Patients With MS on Ocrelizumab
Researchers sought to determine the T-cell and antibody response to the SARS-CoV-2 vaccine in patients with multiple sclerosis treated with ocrelizumab, compared with healthy individuals.
Immunity, T-Cell Responses in Patients Vaccinated Against SARS-CoV-2 With Low-Dose mRNA-1273
Investigators conducted a study to assess immune responses among individuals vaccinated against SARS-CoV-2 infection with low-dose mRNA-1273.
Johnson & Johnson Seeks FDA Emergency Approval for Its Booster Shot
FDA advisory panel will review J&J data next week and vote on whether to recommend boosters
US to Buy $1 Billion Worth of Rapid COVID-19 Tests
Many Americans have reported difficulty getting testing appointments or buying at-home tests.
BNT162b2 Provides 6 Months of Protection Against COVID-19 Hospitalization
Effectiveness of full vaccination against SARS-CoV-2 infections caused by the delta variant or other variants wanes more quickly.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...